Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6490830 | 0.79 | RAB9A (0.32) | ALDH1A1RAB9AMAPTMEN1LMNA | |
| SCHEMBL27324699 | 0.79 | ALDH1A1 (0.40) | ALDH1A1RAB9AMAPTMEN1LMNA | |
| SCHEMBL6479332 | 0.70 | CYP1A2 (0.48) | — | |
| SCHEMBL6482738 | 0.67 | CYP1A2 (0.30) | — | |
| Acrylic Acid Methyl Ester SCHEMBL27679174 | 0.63 | ALOX15 (0.39) | ALDH1A1RAB9AMAPTHTT | |
| SCHEMBL5473940 | 0.62 | ESR2 (0.48) | ALDH1A1MAPTMEN1LMNAHPGD | |
| SCHEMBL6480327 | 0.60 | FABP7 (0.35) | KMT2A | |
| SCHEMBL12666796 | 0.59 | ALDH1A1 (0.35) | ALDH1A1MAPTMEN1LMNAKMT2A | |
| SCHEMBL518574 | 0.59 | — | — | |
| SCHEMBL23087148 | 0.59 | HCAR2 (0.46) | ALDH1A1MAPTMEN1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288238-A1 | Benzocyclodecane derivatives with antitumor activity | PFIZER INC | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288238-A1 | Benzocyclodecane derivatives with antitumor activity | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, OR10J3, BCL6 | ALDH1A1 1416/4885RAB9A 172/4885MAPT 4686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.